EATONTOWN, N.J., Jan. 6, 2014 (GLOBE NEWSWIRE) -- John Arnone, Chairman and CEO of American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today issued a formal update in the form of a Letter to Shareholders posted to the Company’s web site at www.americancryosystem.com.
Help employers find you! Check out all the jobs and post your resume.
